David T Paik1, Meena Rai1, Sergey Ryzhov1, Lehanna N Sanders1, Omonigho Aisagbonhi1, Mitchell J Funke1, Igor Feoktistov1, Antonis K Hatzopoulos2. 1. From the Division of Cardiovascular Medicine, Department of Medicine (D.T.P., M.R., S.R., L.N.S., O.A., M.J.F., I.F., A.K.H.), Department of Cell and Developmental Biology (D.T.P., M.R., L.N.S., O.A., A.K.H.), and Department of Pharmacology, Vanderbilt University, Nashville, TN (I.F.); Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough (S.R.); Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston (O.A.); and Golden Rule Medical, Cincinnati, OH (M.J.F.). 2. From the Division of Cardiovascular Medicine, Department of Medicine (D.T.P., M.R., S.R., L.N.S., O.A., M.J.F., I.F., A.K.H.), Department of Cell and Developmental Biology (D.T.P., M.R., L.N.S., O.A., A.K.H.), and Department of Pharmacology, Vanderbilt University, Nashville, TN (I.F.); Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough (S.R.); Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston (O.A.); and Golden Rule Medical, Cincinnati, OH (M.J.F.). antonis.hatzopoulos@vanderbilt.edu.
Abstract
RATIONALE: Myocardial infarction causes irreversible tissue damage, leading to heart failure. We recently discovered that canonical Wnt signaling and the Wnt10b ligand are strongly induced in mouse hearts after infarction. Wnt10b regulates cell fate in various organs, but its role in the heart is unknown. OBJECTIVE: To investigate the effect of Wnt10b gain-of-function on cardiac repair mechanisms and to assess its potential to improve ventricular function after injury. METHODS AND RESULTS: Histological and molecular analyses showed that Wnt10b is expressed in cardiomyocytes and localized in the intercalated discs of mouse and human hearts. After coronary artery ligation or cryoinjury in mice, Wnt10b is strongly and transiently induced in peri-infarct cardiomyocytes during granulation tissue formation. To determine the effect of Wnt10b on neovascularization and fibrosis, we generated a mouse line to increase endogenous Wnt10b levels in cardiomyocytes. We found that gain of Wnt10b function orchestrated a recovery phenotype characterized by robust neovascularization of the injury zone, less myofibroblasts, reduced scar size, and improved ventricular function compared with wild-type mice. Wnt10b stimulated expression of vascular endothelial growth factor receptor 2 in endothelial cells and angiopoietin-1 in vascular smooth muscle cells through nuclear factor-κB activation. These effects coordinated endothelial growth and smooth muscle cell recruitment, promoting robust formation of large, coronary-like blood vessels. CONCLUSION: Wnt10b gain-of-function coordinates arterial formation and attenuates fibrosis in cardiac tissue after injury. Because generation of mature blood vessels is necessary for efficient perfusion, our findings could lead to novel strategies to optimize the inherent repair capacity of the heart and prevent the onset of heart failure.
RATIONALE: Myocardial infarction causes irreversible tissue damage, leading to heart failure. We recently discovered that canonical Wnt signaling and the Wnt10b ligand are strongly induced in mouse hearts after infarction. Wnt10b regulates cell fate in various organs, but its role in the heart is unknown. OBJECTIVE: To investigate the effect of Wnt10b gain-of-function on cardiac repair mechanisms and to assess its potential to improve ventricular function after injury. METHODS AND RESULTS: Histological and molecular analyses showed that Wnt10b is expressed in cardiomyocytes and localized in the intercalated discs of mouse and human hearts. After coronary artery ligation or cryoinjury in mice, Wnt10b is strongly and transiently induced in peri-infarct cardiomyocytes during granulation tissue formation. To determine the effect of Wnt10b on neovascularization and fibrosis, we generated a mouse line to increase endogenous Wnt10b levels in cardiomyocytes. We found that gain of Wnt10b function orchestrated a recovery phenotype characterized by robust neovascularization of the injury zone, less myofibroblasts, reduced scar size, and improved ventricular function compared with wild-type mice. Wnt10b stimulated expression of vascular endothelial growth factor receptor 2 in endothelial cells and angiopoietin-1 in vascular smooth muscle cells through nuclear factor-κB activation. These effects coordinated endothelial growth and smooth muscle cell recruitment, promoting robust formation of large, coronary-like blood vessels. CONCLUSION:Wnt10b gain-of-function coordinates arterial formation and attenuates fibrosis in cardiac tissue after injury. Because generation of mature blood vessels is necessary for efficient perfusion, our findings could lead to novel strategies to optimize the inherent repair capacity of the heart and prevent the onset of heart failure.
Authors: Marcus Semones; Yanhong Feng; Neil Johnson; Jerry L Adams; Jim Winkler; Michael Hansbury Journal: Bioorg Med Chem Lett Date: 2007-06-27 Impact factor: 2.823
Authors: Eric Ubil; Jinzhu Duan; Indulekha C L Pillai; Manuel Rosa-Garrido; Yong Wu; Francesca Bargiacchi; Yan Lu; Seta Stanbouly; Jie Huang; Mauricio Rojas; Thomas M Vondriska; Enrico Stefani; Arjun Deb Journal: Nature Date: 2014-10-15 Impact factor: 49.962
Authors: Graeme M Birdsey; Aarti V Shah; Neil Dufton; Louise E Reynolds; Lourdes Osuna Almagro; Youwen Yang; Irene M Aspalter; Samia T Khan; Justin C Mason; Elisabetta Dejana; Berthold Göttgens; Kairbaan Hodivala-Dilke; Holger Gerhardt; Ralf H Adams; Anna M Randi Journal: Dev Cell Date: 2015-01-12 Impact factor: 12.270
Authors: Dikshya Bastakoty; Sarika Saraswati; Piyush Joshi; James Atkinson; Igor Feoktistov; Jun Liu; Jennifer L Harris; Pampee P Young Journal: Cell Stem Cells Regen Med Date: 2016-05-30
Authors: Sergey Ryzhov; Michael P Robich; Daniel J Roberts; Amanda J Favreau-Lessard; Sarah M Peterson; Edward Jachimowicz; Rutwik Rath; Calvin P H Vary; Reed Quinn; Robert S Kramer; Douglas B Sawyer Journal: J Mol Cell Cardiol Date: 2017-12-29 Impact factor: 5.000
Authors: Katherine Zurbrigg; Francesca Bertolini; Muhammed Walugembe; Toni van Dreumel; David Alves; Robert Friendship; Terri L O'Sullivan; Max F Rothschild Journal: Can J Vet Res Date: 2021-04 Impact factor: 1.310
Authors: David T Paik; Lei Tian; Ian M Williams; Siyeon Rhee; Hao Zhang; Chun Liu; Ridhima Mishra; Sean M Wu; Kristy Red-Horse; Joseph C Wu Journal: Circulation Date: 2020-09-15 Impact factor: 29.690
Authors: Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn Journal: Pharmacol Rev Date: 2018-01 Impact factor: 25.468